english.prescrire.org > Prescrire International > N°260 - June 2024

n°260

June 2024

Issue Contents
Editorial

Free  A tale of risk

p.143

Marketing Authorisations


Faricimab (Vabysmo°) in age-related macular degeneration or diabetic macular oedema

p.145-148

Editors' opinion. Hypothetical

p.147

Tofacitinib (Xeljanz°) in ankylosing spondylitis

p.148

Pitolisant (Wakix°) in narcolepsy from 6 years of age

p.149

Darolutamide (Nubeqa°) in combination with docetaxel in metastatic hormone-sensitive prostate cancer

p.150

Dupilumab (Dupixent°) in severe atopic eczema from 6 months of age

p.151

15-valent pneumococcal conjugate vaccine (Vaxneuvance°) in children from 6 weeks of age

p.152

Cemiplimab (Libtayo°) in cervical cancer that has progressed during or after chemotherapy

p.153

Etanercept cartridges (Enbrel°) for the "Smartclic°" injection device

p.154-155

Oseltamivir to treat seasonal influenza?

p.155

Corifollitropin alfa (Elonva°) in hypogonadotropic hypogonadism in adolescent males

p.156

Semaglutide in secondary cardiovascular prevention in overweight or obese patients

p.157-158

Adverse Effects


Paternal exposure to valproate drugs in the period prior to conception: neurodevelopmental disorders in children?

p.159-161

Duloxetine, milnacipran, venlafaxine: gestational hypertension

p.162

Dupilumab: osteoarticular pain

p.163

Pentosan polysulfate: progressive pigmentary maculopathy and reduction in visual acuity

p.163

Short-term treatment with NSAIDs: heart failure

p.164

Common stem: -grastim

p.164

Outlook


Free  The finances of Association Mieux Prescrire: 2023 annual report

p.165

Queries and comments. Recurring criticisms of Prescrire: how do we answer?

p.166-167

Masthead


Free  Masthead

p.142

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe